Search for the latest oncology news by tumour type
A team led by the National Cancer Centre Singapore (NCCS) with members from Singapore General…
First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic…
Saritha Krishna, University of California, San Francisco and Shawn Hervey-Jumper, University of California, San Francisco…
A new study that sheds light on how B cells react to skin cancer cells…
The Menarini Group (“Menarini”), announced important new data on selinexor at the European Hematology Association (EHA) Congress 2023.…
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a…
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma…
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…